Nunn & colleagues explore barriers to PrEP uptake

Brown University School of Public Health's Dr. Amy Nunn and Johns Hopkins Bloomberg School of Public Health colleague Dr. Lorraine Dean led research examining barriers to the HIV pre-exposure prophylaxis drug known as PrEP. Poor uptake of the drug can be attributed to stigma, limited awareness, and lack of accessibility to health care and health insurance.